Results

Total Results: 78 records

Showing results for "choose".

  1. cds.ahrq.gov/sites/default/files/workgroups/58631/CDS_Connect_Work_Group_February_2022_slides.pdf
    January 01, 2022 - Provider and staff are part of my community - ACTIVATE Co-designers Early Co-Design Lessons: Help Me Choose … Approaches Early Co-Design Lessons: Keep My Provider Relationship Early Co-Design Lessons: �Help Me Choose
  2. cds.ahrq.gov/sites/default/files/workgroups/71451/CDS_Connect_WG_March_2022_Summary.pdf
    January 01, 2022 - March 2022 CDS Connect Work Group Summary Clinical Decision Support (CDS) Connect Work Group (WG) Meeting Summary March 17, 2022 3:00 – 4:00 pm ET Attendees: 37 people, including 4 phone dial-ins Organization Attendees AHRQ Sponsors Mario Teran; Roland Gamache; Steve Bernstein (3) WG Members Andrey…
  3. cds.ahrq.gov/sites/default/files/cds/artifact/71/Implementation_Guide_CMS_Million_Hearts_ASCVD_Risk_Assessment.pdf
    September 01, 2021 - Future implementers may choose to represent ASCVD as an exclusion based on their needs. 5. … Future implementers may choose to evaluate and track a “baseline” low-density lipoprotein (LDL) value … Future implementers may choose to represent ASCVD as an exclusion based on their needs. 23 … Implementers may choose to add this capability in the future. … Future implementers may choose to evaluate and track a “baseline” low-density lipoprotein (LDL) value
  4. cds.ahrq.gov/sites/default/files/CDS_Connect_2024_Final_Report.pdf
    January 01, 2024 - Those interested in learning more may choose to sign up for one of AHRQ’s newsletters at https://www.ahrq.gov
  5. cds.ahrq.gov/sites/default/files/cds/artifact/71/Implementation%20Guide_CMS%20Million%20Hearts_ASCVD%20Risk%20Assessment_Level3_Final.pdf
    February 01, 2018 - Future implementers may choose to represent ASCVD as an exclusion based on their needs. 5. … Future implementers may choose to evaluate and track a “baseline” low-density lipoprotein (LDL) value … Future implementers may choose to represent ASCVD as an exclusion based on their needs. … Implementers may choose to add this capability in the future. … Future implementers may choose to evaluate and track a “baseline” low-density lipoprotein (LDL) value
  6. cds.ahrq.gov/sites/default/files/workgroups/1261/CDS_Connect_WG_%20March2021_%20Summary.pdf
    March 18, 2021 - the patient and caregiver community might be more technically proficient than those who currently choose
  7. cds.ahrq.gov/sites/default/files/cds/artifact/71/Implementation%20Guide_CMS%20Million%20Hearts_ASCVD%20Risk%20Assessment_Level3_Sept_08.pdf
    February 01, 2018 - Future implementers may choose to represent ASCVD as an exclusion based on their needs. 5. … Future implementers may choose to evaluate and track a “baseline” low-density lipoprotein (LDL) value … Future implementers may choose to represent ASCVD as an exclusion based on their needs. … Implementers may choose to add this capability in the future. … Future implementers may choose to evaluate and track a “baseline” low-density lipoprotein (LDL) value
  8. cds.ahrq.gov/sites/default/files/workgroups/236/may-2017-cholesterol-wg-notes.docx
    January 01, 2017 - recommendation with a verb: · Look at the GRADE system (e.g., SHOULD means that 90% of the patients would choose
  9. cds.ahrq.gov/sites/default/files/cds/artifact/171/NIOSH_Occupational%20Factors%20Impacting%20Diabetes_Decision%20Log_condensed.pdf
    February 01, 2018 - Future implementers may choose to adjust the time frame based on their preference or organization’s
  10. cds.ahrq.gov/sites/default/files/AHRQ_Final_Report_2021.pdf
    January 01, 2021 - select a value from the dropdown list (e.g., colleague, conference/workshop, university class, etc) or choose … These fields allow authors to choose from example values provided by the FHIR specification or to … For example, an author can choose a code-based property and indicate a set of codes it should match … As another example, an author could choose a quantity-based property and indicate a range it should … Report 21 5.5 Additional Resources and Modifiers The CDS Authoring Tool allows authors to choose
  11. cds.ahrq.gov/sites/default/files/cds/artifact/18/Implementation%20Guide_USPSTF%20Statin%20Use%20for%20the%20Primary%20Prevention%20of%20CVD%20in%20Adults_Final.docx
    October 01, 2017 - Clinicians may choose to offer a low- to moderate-dose statin to certain adults without a history of … Grade C Recommendation Statement Clinicians may choose to offer a low- to moderate-dose statin to certain … intensity statin based on outcome of shared decision between patient and provider) Grade C "may choose
  12. cds.ahrq.gov/sites/default/files/cds/artifact/1071/2024_CDS_Connect_IG_Healthy_Diet_Physical_Activity.pdf
    January 01, 2024 - Organizations that elect to implement this code will likely choose to expand upon the CDS intervention … Future implementers may choose to utilize other definitions (e.g., some definitions list different waist … Alternatively, they may choose to map qualifying data in their system to the CQL code and value sets … Future implementers may choose to implement other definitions (e.g., some definitions list different … Alternatively, they may choose to map qualifying data in their system to the CQL code as is.
  13. cds.ahrq.gov/sites/default/files/workgroups/246/jul-2017-cholesterol-wg-notes.docx
    January 01, 2017 - Clinicians and quality leaders (e.g., how to choose and understand the best algorithm or modify the algorithm
  14. cds.ahrq.gov/sites/default/files/cds/artifact/1141/Warfarin-NSAIDs%20MDIA%20Implementation%20Guide.docx
    November 11, 2019 - Implementation Guide Warfarin - NSAIDs Prepared by: Eric Chou Under funding from AHRQ grants R21 HS023826 and R01 HS025984 MDIA publication No. 001 November 11, 2019 Disclaimer The findings and conclusions in this document are those of the author(s), who are responsible for its content, and do not necessarily represen…
  15. cds.ahrq.gov/sites/default/files/cds/artifact/476/2024_CDS_Connect_IG_Pain_Management_Summary.pdf
    January 01, 2024 - Vendors and integrators may also choose to use the CQL Testing https://cds.ahrq.gov/cdsconnect/repository … Future implementers may choose to support patients younger than 18. … clinician via a link in the EHR during the MITRE pilot of this work, the clinician or health system may choose … Future implementers of this artifact may choose to include alerts reinforcing specific CDC or other … Future implementers may choose to remove this criterion or expand the inclusion logic.
  16. cds.ahrq.gov/sites/default/files/cds/artifact/26/Implementation%20Guide_Aspirin%20Therapy%20for%20the%20Prevention%20of%20CVD%20and%20CRC_final.pdf
    January 01, 2020 - Vendors and integrators may also choose to use the CQL Testing Framework to test any site- or product-specific … Persons who place a higher value on the potential 12 benefits than the potential harms may choose … Persons who place a higher value on the potential benefits than the potential harms may choose to initiate
  17. cds.ahrq.gov/sites/default/files/cds/artifact/1071/Implementation%20Guide_Healthful%20Diet%20and%20Physical%20Activity_Final.pdf
    September 01, 2019 - Organizations that elect to implement this code will likely choose to expand upon the CDS intervention … Future implementers may choose to utilize other definitions (e.g., some definitions list different waist … Alternatively, they may choose to map qualifying data in their system to the CQL code and value sets … Future implementers may choose to implement other definitions (e.g., some definitions list different … Alternatively, they may choose to map qualifying data in their system to the CQL code as is.
  18. cds.ahrq.gov/sites/default/files/cds/artifact/18/Implementation%20Guide_Statin%20Use%20for%20CVD%20Prevention%20in%20Adults_Clinician%20Facing%20CDS%20Intervention.pdf
    January 01, 2020 - Vendors and integrators may also choose to use the CQL Testing Framework to test any site- or product-specific … Organizations that elect to implement this code will likely choose to expand upon the CDS intervention … patients is moderate to substantial.6 The recommendation summary also states that “clinicians may choose … cardiovascular event of 10 percent or greater.”2 The USPSTF recommendation summary also states, “clinicians may choose … 7.5 percent – 10 percent for the Grade C recommendaiton.2 Future implementers can elect whether they choose
  19. cds.ahrq.gov/sites/default/files/cds/artifact/26/Implementation%20Guide_USPSTF%20Aspirin%20Therapy%20for%20the%20Prevention%20of%20CVD%20and%20CRC_Final.docx
    October 01, 2017 - Persons who place a higher value on the potential benefits than the potential harms may choose to initiate … Persons who place a higher value on the potential benefits than the potential harms may choose to initiate
  20. cds.ahrq.gov/sites/default/files/cds/artifact/26/Implementation%20Guide_Aspirin%20Therapy%20for%20the%20Prevention%20of%20CVD%20and%20CRC_final_2.pdf
    April 01, 2021 - Vendors and integrators may also choose to use the CQL Testing Framework to test any site- or product-specific … Persons who place a higher value on the potential benefits than the potential harms may choose to initiate … Persons who place a higher value on the potential benefits than the potential harms may choose to initiate

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: